Cameco's $1.9bn India Contract Puts Market Value on Australia's Uranium Corridor
A long-term supply deal announced after Modi's Melbourne visit exposes listed uranium equities to Indian reactor demand through 2035.
A $1.9 billion long-term uranium supply contract, detailed in Indian media analysis on Monday (2026-07-13), has attached the first concrete market figure to the Australia-India civil nuclear deal announced during Prime Minister Narendra Modi's visit to Melbourne on July 9 (2026-07-09). Under the arrangement, Canada's Cameco will supply nearly 22 million pounds of uranium ore concentrate (U3O8) to India's Department of Atomic Energy between 2027 and 2035 on market-related price terms.5,3
The uranium ETF URA gained 2.71% to $41.65 by Tuesday afternoon (2026-07-14), as markets priced in the opening of a demand corridor discussed for more than 15 years but never formalised. India has set a target of 1,000 GW of nuclear energy by 2047, a build-out that would require sustained fuel deliveries at a scale no country has yet achieved.5
The path to July 9 (2026-07-09) was unusually long. Australia and India first agreed in principle to explore a uranium supply arrangement during Prime Minister Kevin Rudd's visit to New Delhi on November 12, 2009 (2009-11-12), when a joint statement acknowledged India's plans to develop nuclear energy. Australian concerns about civilian nuclear safeguards held up implementation for years. The Melbourne announcement resolved the outstanding administrative arrangements that had kept Australian uranium off the export ledger.5,4
India is not a signatory to the Nuclear Non-Proliferation Treaty, a status that has historically made Western suppliers reluctant to sell it fuel. Australia's Shanti Agreement framework permits uranium exports to non-NPT states under specific safeguard conditions. Applying it to India required Canberra to satisfy itself that India's civilian reactors were adequately separated from its weapons programme — a determination that took 16 years to formalise.4
The supply side is where analyst attention will concentrate. Goldman Sachs analyst Brian Lee warned in a note from May (2026-05-19) of a cumulative uranium supply deficit of 2.3 billion pounds between 2025 and 2045, before accounting for small modular reactors. Lee's updated model projects nearly 46 GW of cumulative SMR deployments by 2045, which would add another 62 million pounds of uranium demand and lift Goldman's 2045 demand forecast by around 17%. The World Nuclear Association separately projects demand climbing roughly 28% by 2030 and more than doubling by 2040.2,1
Few producers have the scale to meet that kind of growth. Cameco produced about 17% of global uranium in 2024, second only to Kazakhstan's Kazatomprom at 21%. Orano, the French company, sits at 11%. That three-producer concentration means the deficit scenario is not abstract if India's construction programme accelerates toward its stated targets.1
The contract's market-related pricing structure means Cameco's India revenue will track spot and long-term uranium price benchmarks rather than fixed offtake rates, giving listed uranium equities more direct exposure to any price move driven by Indian demand than a locked-in price would allow.3,5
For India, the deal diversifies uranium sourcing and adds international credibility to its civilian nuclear programme. The $1.9 billion contract value was cited by The Hindu on Monday (2026-07-13) as a signal of improving investment appetite in the sector.5
The harder question is pace. India's 1,000 GW nuclear target by 2047 implies a rate of reactor addition unprecedented in modern energy history. The Cameco supply arrangement begins in 2027, but whether Indian reactor construction can absorb the contracted volume on schedule depends on factors the Melbourne visit did not resolve: regulatory speed, grid integration capacity and the financing of what would be the largest nuclear build programme ever attempted.5,3